CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: October 30, 2013
Result type: Reports
Project Number: SR0360-000
Product Line: Reimbursement Review

Generic Name: Stiripentol

Brand Name: Diacomit

Manufacturer: Biocodex

Therapeutic Area: Dravet Syndrome

Indications: Dravet Syndrome

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: October 16, 2014

Recommendation Type: List with criteria/condition